Testing new eye drops for pupil dilation
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests whether a special eye drop (MydCombi) works as well as or better than the standard drops for widening pupils during an eye exam. It includes both children and adults who need their pupils dilated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must need your pupils dilated in both eyes as part of your regular eye care.
- You cannot have any unusual pupil shape, movement, or problems with the front part of your eye.
- You must not have any health condition that would make pupil dilation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well two different eye drops (pilocarpine and phentolamine) work to reverse the effects of the dilation drops used in children's eye exams. It aims to find a faster way to bring the pupils back to normal.
This study checks how well a device can measure how your pupils respond to colored light. It may help improve eye testing, especially when monitoring certain vision and nerve conditions.
This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study looks at how different colors of light change your pupil size. It may help us understand vision and eye health better.
This study looks at how different pain treatments affect a child’s pupils (the dark center of the eye). It may help doctors better understand which pain medicines are working and how to measure pain treatment effects more accurately.
Hear when a new Dilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.